Articles published by TherapeuticsMD, Inc.
![](https://www.businesswire.com/images/bwlogo_extreme.png)
TherapeuticsMD Announces Second Quarter 2024 Financial Results
August 12, 2024
From TherapeuticsMD, Inc.
Via Business Wire
Tickers
TXMD
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://mms.businesswire.com/media/20240329541788/en/1306507/22/TXMD_logo.jpg)
TherapeuticsMD Announces Full Year 2023 Financial Results
March 29, 2024
From TherapeuticsMD, Inc.
Via Business Wire
Tickers
TXMD
![](https://mms.businesswire.com/media/20231114765105/en/1306507/22/TXMD_logo.jpg)
TherapeuticsMD Announces Third Quarter 2023 Financial Results
November 14, 2023
From TherapeuticsMD, Inc.
Via Business Wire
Tickers
TXMD
![](https://mms.businesswire.com/media/20230814067667/en/1306507/22/TXMD_logo.jpg)
TherapeuticsMD Announces Second Quarter 2023 Financial Results
August 14, 2023
From TherapeuticsMD, Inc.
Via Business Wire
Tickers
TXMD
![](https://mms.businesswire.com/media/20230515005776/en/1306507/22/TXMD_logo.jpg)
![](https://mms.businesswire.com/media/20230407005027/en/1306507/22/TXMD_logo.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma
December 04, 2022
From TherapeuticsMD, Inc.
Via Business Wire
Tickers
TXMD
![](https://mms.businesswire.com/media/20221114005733/en/1306507/4/TXMD_logo.jpg)
TherapeuticsMD Announces Third Quarter 2022 Financial Results
November 14, 2022
From TherapeuticsMD, Inc.
Via Business Wire
Tickers
TXMD
![](https://mms.businesswire.com/media/20221031005134/en/1306507/4/TXMD_logo.jpg)
TherapeuticsMD Announces Additional $7 Million Private Placement
October 31, 2022
From TherapeuticsMD, Inc.
Via Business Wire
Tickers
TXMD
![](https://www.businesswire.com/images/bwlogo_extreme.png)
TherapeuticsMD Announces $7 Million Private Placement
October 03, 2022
From TherapeuticsMD, Inc.
Via Business Wire
Tickers
TXMD
![](https://mms.businesswire.com/media/20220912005338/en/1306507/4/TXMD_logo.jpg)
TherapeuticsMD Appoints Dr. Brian Bernick and Mr. Mark Glickman as Interim Co-Chief Executive Officers
September 12, 2022
From TherapeuticsMD, Inc.
Via Business Wire
Tickers
TXMD
![](https://www.businesswire.com/images/bwlogo_extreme.png)
TherapeuticsMD Announces Second Quarter 2022 Financial Results
August 15, 2022
From TherapeuticsMD, Inc.
Via Business Wire
Tickers
TXMD
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
TherapeuticsMD Announces Expiration of Tender Offer
July 13, 2022
From TherapeuticsMD, Inc.
Via Business Wire
Tickers
TXMD
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://mms.businesswire.com/media/20220520005266/en/1306507/4/TXMD_logo.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://mms.businesswire.com/media/20220510006292/en/1306507/4/TXMD_logo.jpg)
![](https://mms.businesswire.com/media/20220414005558/en/1421621/4/TXMD_logo.jpg)
![](https://mms.businesswire.com/media/20211210005546/en/935475/4/TXMD_logo.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
TherapeuticsMD Announces Third Quarter 2021 Financial Results
November 11, 2021
From TherapeuticsMD, Inc.
Via Business Wire
Tickers
TXMD
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://mms.businesswire.com/media/20211027006142/en/920929/4/TXMD_logo.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
TherapeuticsMD Announces Issuance of a J-Code for ANNOVERA® to Be Utilized in the Public Health Sector
August 23, 2021
From TherapeuticsMD, Inc.
Via Business Wire
Tickers
TXMD
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.